MK-329 - A NONPEPTIDE CHOLECYSTOKININ-A ANTAGONIST

被引：2

作者：

EVANS, BE

机构：

[1] Department of Medicinal Chemistry, Merck Research Laboratories, West Point, Pennsylvania

来源：

DRUG DEVELOPMENT RESEARCH | 1993年 / 29卷 / 04期

关键词：

CCK RECEPTOR ANTAGONISTS; MK-329; MEDICINAL CHEMISTRY;

D O I：

10.1002/ddr.430290402

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Peptide receptors represent important targets for a variety of potentially important disease modifying drugs. Over the past 20 years, considerable effort has been spent on modifying the natural ligands for peptide receptors, the peptides themselves, with limited success. Using a targeted screen, namely cholecystokinin (CCK)-A receptor binding, the Merck group in 1984 discovered asperlicin, a potent non-peptide cholecystokinin antagonist selective for peripheral tissues, that was isolated from Aspergillus alliaceaus. This compound was used as a lead to develop MK-329, a CCK-A receptor antagonist, the evolution of which is discussed within the context of the drug discovery process and receptor modeling strategies. (C) 1993 Wiley-Liss, Inc.

引用

收藏

页码：255 / 261

页数：7

相关论文

共 14 条

[1]

ARIENS EJ, 1979, RECEPTORS COMPREHENS, V1, P33

[2]

BERLIN RG, 1991, CCK ANTAGONISTS GAST, P70

[3] BENZODIAZEPINE GASTRIN AND BRAIN CHOLECYSTOKININ RECEPTOR LIGANDS - L-365,260 [J].

BOCK, MG ;

DIPARDO, RM ;

EVANS, BE ;

RITTLE, KE ;

WHITTER, WL ;

VEBER, DF ;

ANDERSON, PS ;

FREIDINGER, RM .

JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (01) :13-16

[4] BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF AN EXTREMELY POTENT AND SELECTIVE NONPEPTIDE CHOLECYSTOKININ ANTAGONIST [J].

CHANG, RSL ;

LOTTI, VJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4923-4926

[5] A POTENT NONPEPTIDE CHOLECYSTOKININ ANTAGONIST SELECTIVE FOR PERIPHERAL-TISSUES ISOLATED FROM ASPERGILLUS-ALLIACEUS [J].

CHANG, RSL ;

LOTTI, VJ ;

MONAGHAN, RL ;

BIRNBAUM, J ;

STAPLEY, EO ;

GOETZ, MA ;

ALBERSSCHONBERG, G ;

PATCHETT, AA ;

LIESCH, JM ;

HENSENS, OD ;

SPRINGER, JP .

SCIENCE, 1985, 230 (4722) :177-179

[6] METHODS FOR DRUG DISCOVERY - DEVELOPMENT OF POTENT, SELECTIVE, ORALLY EFFECTIVE CHOLECYSTOKININ ANTAGONISTS [J].

EVANS, BE ;

RITTLE, KE ;

BOCK, MG ;

DIPARDO, RM ;

FREIDINGER, RM ;

WHITTER, WL ;

LUNDELL, GF ;

VEBER, DF ;

ANDERSON, PS ;

CHANG, RSL ;

LOTTI, VJ ;

CERINO, DJ ;

CHEN, TB ;

KLING, PJ ;

KUNKEL, KA ;

SPRINGER, JP ;

HIRSHFIELD, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (12) :2235-2246

[7] DESIGN OF POTENT, ORALLY EFFECTIVE, NONPEPTIDAL ANTAGONISTS OF THE PEPTIDE-HORMONE CHOLECYSTOKININ [J].

EVANS, BE ;

BOCK, MG ;

RITTLE, KE ;

DIPARDO, RM ;

WHITTER, WL ;

VEBER, DF ;

ANDERSON, PS ;

FREIDINGER, RM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (13) :4918-4922

[8] DESIGN OF NONPEPTIDAL LIGANDS FOR A PEPTIDE RECEPTOR - CHOLECYSTOKININ ANTAGONISTS [J].

EVANS, BE ;

RITTLE, KE ;

BOCK, MG ;

DIPARDO, RM ;

FREIDINGER, RM ;

WHITTER, WL ;

GOULD, NP ;

LUNDELL, GF ;

HOMNICK, CF ;

VEBER, DF ;

ANDERSON, PS ;

CHANG, RSL ;

LOTTI, VJ ;

CERINO, DJ ;

CHEN, TB ;

KING, PJ ;

KUNKEL, KA ;

SPRINGER, JP ;

HIRSHFIELD, J .

JOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (07) :1229-1239

[9]

EVANS BE, 1993, ADV MED CHEM, V2, P111

[10] MEDICINAL CHEMISTRY IN THE GOLDEN-AGE OF BIOLOGY - LESSONS FROM STEROID AND PEPTIDE RESEARCH [J].

HIRSCHMANN, R .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1991, 30 (10) :1278-1301